Clovis Oncology, Inc.
CLVSDelisted Dec 29, 2022- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001466301
Clovis Oncology, Inc. was delisted on Dec 29, 2022; its insiders filed their last Form 4 on Nov 3, 2022; 103 institutions reported holding it in 13F filings for Q3 2022, worth $42.6M in total; no superinvestor held it.
Q4 2022 vs. Q3 2022
How the institutions holding Clovis Oncology, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 103 | 15 | −88 |
| Shares | 35.8M | 400.6K | −35.4M (−98.9%) |
| Value | $42.6M | $20.1K | −$42.5M (−100.0%) |
New holders (2)
Institutions that held Clovis Oncology, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 265 | – | – |
| Coppell Advisory Solutions Corp. | 265 | – | – |
Sold out (90)
Institutions that held Clovis Oncology, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.